OVERVIEW
IBERFAR is part of a privately-owned Portuguese pharmaceutical group whose activities cover all major industry fields:
As a specialist contract manufacturing company, dedicated to the secondary pharmaceutical industry, IBERFAR is committed to providing to its clients the most comprehensive range of services, at the highest levels of quality, with the shortest lead times and at the fairest market prices.
IBERFAR owns FERRAZ LYNCE (marketing, regulatory affairs, and distribution) and LOGIFARMA (pharmaceutical logistics).
This group of pharmaceutical companies was founded in 1924. IBERFAR started the manufacturing activity in 1951 and built their first industrial facilities in 1965.
IBERFAR’s facilities have been successively enlarged to match the continuous growth of the business.
LOCATION
IBERFAR have their headquarters in a self-owned 20,000 square-meter property located in the industrial area of Queluz de Baixo (Barcarena).
This is in the outskirts of the capital, Lisbon, close to the airport (about 15 Km) and the seaport, with easy access to all major roadways linking Lisbon to all points of the country, to Europe and the rest of the world.
ADDRESS & CONTACTS
IBERFAR, INDÚSTRIA FARMACÊUTICA, S.A.
Rua Consiglieri Pedroso, 123, Apartado 1011, Queluz de Baixo, 2734-501 Barcarena, Portugal – EU
Phone: +351 21 434 81 00
Fax: +351 21 434 81 01
Email: geral@iberfar.pt
Pedro Ferraz da Costa, CMO Iberfar’s president, discusses generic competition in Portugal, his company’s expansion into Angola and southern Africa, and the company’s competitive advantages with its various subsidiaries. There…
Portugal boasts a well-developed universal healthcare system and saw healthcare spending increase by 6.2 percent annually between 2016 and 2021, according to the OECD. However, the representatives of innovative medicines…
Dr Maria Mota, executive director at Portugal’s Institute of Molecular Medicine (iMM), shares how the non-profit institute generated its own circular economy during the COVID-19 pandemic and saved the Portuguese…
Pedro Moura, managing director at Merck Portugal, outlines the company’s unique presence and the Portuguese affiliate’s diverse portolio. He discusses the challenges around access to innovation in Portugal, where only…
Country manager at Lundbeck Portugal, Sara Barros, came to the Danish company after a number of management positions at larger pharma companies and took on the leadership of its local…
President of the Portuguese Association Against Leukaemia (APCL), Dr Manuel Abecasis is known as the father of bone marrow transplants in Portugal. He outlines the APCL’s activities, including the organisation’s…
Speaking to PharmaBoardroom as Janseen is rebranding as Johnson & Johnson Innovative Medicine, managing director for Portugal, Filipa Mota e Costa, discusses the affiliate’s expanded local footprint and its ranking…
A doyen of Portuguese pharma, Pedro Ferraz da Costa is the long-serving president of the company started by his parents, Iberfar. In conversation with PharmaBoardroom, he discusses how Iberfar’s business…
Last year, Tecnimede Group – a family-owned titan of the Portuguese healthcare industry – appointed its first professional, non-family CEO in Antonio Donato. This marked a significant milestone in the…
Portugal’s strong legal framework along with its low production costs and strategic location within Europe have given rise to a thriving medicinal cannabis sector. With exports in 2022 that surpassed…
Erstwhile 21-year CEO of leading Portuguese generics group Tecnimede, Maria do Carmo Neves today serves as president of her country’s generics industry association, APOGEN. She outlines the highly challenging market…
Speaking from Servier’s new open-plan office in Lisbon, a space aimed at promoting cross-functional integration and “collective intelligence,” experienced industry executive Frédéric Bengold looks back on three successful years at…
P-BIO, Portugal’s leading association for its biotech industry, is approaching a quarter century in existence. Its president, Simão Soares, tells PharmaBoardroom that there has been “substantial positive change” in the…
See our Cookie Privacy Policy Here
